Ultralife (ULBI) Stock Price, News & Analysis

Company Overview

Ultralife Corporation develops, manufactures and supplies battery and communications products for government, defense, industrial, medical and commercial customers. The company’s offerings include lithium-ion and lithium primary batteries, rechargeable battery systems, battery packs, chargers and related power accessories.

Through its communications business, Ultralife also provides equipment and components such as tactical communication systems, power supplies, amplifiers, cable assemblies and other products designed to support portable and field-based communications. Its products are used in applications that require reliable power and communications in demanding operating environments.

Founded in 1990 and headquartered in Newark, New York, Ultralife serves customers in the United States and international markets. The company’s leadership includes Michael D. Popielec, who has served as president and chief executive officer.

Key Stats

• Today's Range: $6.39 to $6.86
• 50-Day Range: $5.16 to $7.51
• 52-Week Range: $4.90 to $8.25
• Volume: 19,814 shs
• Average Volume: 43,988 shs
• Market Capitalization: $108.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Ultralife Stock Analysis - MarketRank™

Ultralife scored higher than 25% of companies evaluated by MarketBeat, and ranked 572nd out of 666 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Ultralife has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Ultralife has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ultralife is -16.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ultralife is -16.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Ultralife has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.10% of the float of Ultralife has been sold short.

Short Interest Ratio / Days to Cover

Ultralife has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ultralife has recently decreased by 5.53%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ultralife does not currently pay a dividend.

Dividend Growth

Ultralife does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Ultralife has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Industrials companies.

Search Interest

Only 1 people have searched for ULBI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added Ultralife to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ultralife insiders have not sold or bought any company stock.

Percentage Held by Insiders

42.90% of the stock of Ultralife is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

30.68% of the stock of Ultralife is held by institutions.

Company Calendar

• Last Earnings: 8/07/2026
• Today: 10/02/2026
• Next Earnings (Estimated): 10/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Industrials
• Industry: Electrical Equipment
• Sub-Industry: Electrical Components & Equipment
• Current Symbol: NASDAQ:ULBI
• CIK: 875657
• Web: www.ultralifecorporation.com
• Phone: (315) 332-7100
• Fax: 315-331-7800
• Employees: 678
• Year Founded: 1990

Profitability

• EPS (Trailing Twelve Months): ($0.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.90 million
• Net Margins: -3.50%
• Pretax Margin: -5.15%
• Return on Equity: 2.75%
• Return on Assets: 1.66%

Debt

• Debt-to-Equity Ratio: 0.32
• Current Ratio: 2.87
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $191.16 million
• Price / Sales: 0.57
• Cash Flow: $0.61 per share
• Price / Cash Flow: 10.74
• Book Value: $7.82 per share
• Price / Book: 0.83

Miscellaneous

• Outstanding Shares: 16,660,000
• Free Float: 9,515,000
• Market Cap: $108.46 million
• Optionable: No Data
• Beta: 0.78